Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Karyopharm Therapeutics (KPTI) Q2 2023 Earnings
KPTI
+3.85%
2
Aug
Confirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.57
-0.48
-0.38
-0.29
Details
Expected EPS
-0.34
Actual EPS
-0.29
Surprise EPS
0.05
Surprise Percent
+14.71%
Description
Karyopharm Therapeutics (KPTI) has reported earnings of -0.29 per share for Q2 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login